Bartłomiej Błaszkowski

Bartłomiej Błaszkowski

Auto-generated profile, based on publicly available information

Bartłomiej Błaszkowski

F. Ceynowa Specialist Hospital, ul. Powstańców Warszawy 11, 84‑200 Wejherowo, Poland

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 February 2026 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
RCRoman Cemaga
Roman Cemaga
PHPatryk Hebda
Patryk Hebda
Mieszko CzaplinskiMieszko Czaplinski
Mieszko Czaplinski
ESEwa Szplit
Ewa Szplit
MPMikołaj Patalong
Mikołaj Patalong
MKMateusz Kubicki
Mateusz Kubicki
Background: Cancers remain a leading cause of mortality in a modern society, and their incidence is growing each year. The disease and its related therapies cause considerable side effects, functional deterioration, and reduce quality of life (QoL), all of which correlate with less favourable outcomes. Physical activity (PA) represents a cost-effective and non-invasive adjunct to the traditional therapy regimes, which can alleviate these negative effects and improve clinical outcomes Aim: The narrative review summarises current evidence about the role of PA in oncology. It provides a solid background in biochemical mechanisms involved in the modulation of cancer biology and evaluates its clinical significance by assessing psychological, physiological, cognitive, QoL and mortality rates Methods: We conducted a narrative review of the available literature on the role of physical activity in modulating physiological and functional parameters, as well as mortality, in cancer patients. We considered original studies, reviews, systematic reviews and meta-analyses. Results: Evidence indicates that PA is an effective tool in both the prevention and management of cancers. Patients who engage in PA have improved metabolic, immune and oxidative stress parameters, which provide clinical outcomes such as improved QoL, cognitive, psychological and physiological performance. This consequently leads to a better prevention of cancers and provides benefits in terms of overall survival Conclusions: PA is an effective strategy for enhancing clinical outcomes in the cancer population and should be considered as an additional approach integrated into clinical guidelines.

26 February 2026 in Quality in Sport
Verified
Journal Article
Open access
PDF file
MKMaria Król
Maria Król
MPMikołaj Patalong
Mikołaj Patalong
BBBartłomiej Błaszkowski
Bartłomiej Błaszkowski
PKPrzemysław Kołodziej
Przemysław Kołodziej
Mieszko CzaplinskiMieszko Czaplinski
Mieszko Czaplinski
RCRoman Cemaga
Roman Cemaga
Background: Iron deficiency is one of the most common nutritional deficiencies in athletes and is particularly prevalent in endurance disciplines. Even without anemia, reduced iron availability may impair aerobic performance, increase fatigue, and affect training adaptation. Objective: This scoping review aimed to evaluate the impact of iron deficiency, with or without anemia, on athletic performance and fatigue in endurance athletes. Methods: A literature search was conducted in PubMed and Google Scholar. Peer-reviewed studies published in English between 2000 and 2026 were included. Eligible studies assessed iron status in endurance athletes in relation to performance, fatigue, or exercise-induced changes in iron metabolism. Studies involving non-athletic populations, children or adolescents, animal models, and case reports were excluded. Results: Iron deficiency was consistently reported as highly prevalent among endurance athletes, particularly females. Athletes with depleted iron stores frequently demonstrated reduced aerobic capacity, lower VO₂peak, and increased fatigue, even in the absence of anemia. Exercise-induced elevations in hepcidin were commonly observed, especially during periods of intensified training, potentially limiting iron absorption and availability. Iron supplementation was associated with improvements in aerobic performance and fatigue in iron-deficient athletes, particularly when baseline ferritin levels were low. Conclusion: Iron deficiency is a clinically relevant condition in endurance athletes and may impair performance and increase fatigue even without anemia. Regular monitoring of iron status and individualized management strategies are essential to support health and performance in endurance sports.

27 January 2026 in Quality in Sport
Verified
Journal Article
Open access
NBNatalia Marta Bruska
Natalia Marta Bruska
ABAndrii Bilyk
Andrii Bilyk
MKMateusz Kubicki
Mateusz Kubicki
AWAdam Wolski
Adam Wolski
PKPrzemysław Kołodziej
Przemysław Kołodziej
Mieszko CzaplinskiMieszko Czaplinski
Mieszko Czaplinski
Background:Mental health disorders are increasingly recognized among athletes and may affect performance, well-being, and career longevity. Pharmacological treatment is often required; however, the use of psychotropic medications in athletes raises specific clinical concerns related to safety, performance, and adverse effects, as well as legal issues associated with anti-doping regulations. Aim:The aim of this narrative review was to summarize evidence on the clinical safety, performance-related effects, and legal implications of psychotropic medication use in athletes, with emphasis on anti-doping regulations. Materials and Methods:A narrative review of the scientific literature was conducted using publications from PubMed, clinical guidelines, and official documents from the World Anti-Doping Agency (WADA). Original studies, systematic reviews, meta-analyses, clinical guidelines, and regulatory documents addressing psychotropic medication use in athletic populations were included. Articles focusing exclusively on non-athletic populations without relevance to physical performance or regulatory aspects were excluded. Results:Available evidence indicates that selective serotonin reuptake inhibitors (SSRIs), bupropion, atomoxetine, and melatonin are among the most frequently preferred pharmacological options in athletes suffering from mental health disorders such as depression, ADHD and insomnia due to their favorable safety profiles and limited impact on physical and cognitive performance. Stimulant medications, although recommended as first-line therapy for ADHD in the general population, require careful consideration in athletes because of regulatory restrictions and the need for Therapeutic Use Exemptions (TUEs). Available evidence on antipsychotic use in athletes is limited. Importantly, untreated mental health conditions were associated with poorer functional outcomes than those observed with appropriately monitored pharmacotherapy.

17 February 2026 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
Mieszko CzaplinskiMieszko Czaplinski
Mieszko Czaplinski
MKMaria Król
Maria Król
NBNatalia Marta Bruska
Natalia Marta Bruska
ABAndrii Bilyk
Andrii Bilyk
PPPaweł Pustuła
Paweł Pustuła
AWAdam Wolski
Adam Wolski
Background: kidney thyroidization is a histological pattern - atrophic renal tubules filled with eosinophilic, colloid-like casts resembling thyroid follicles. Regarded as a nonspecific marker of chronicity in renal disease, yet its biological significance, clinical correlations, and prognostic value remain poorly defined. Aim: to synthesize the existing literature on renal thyroidization. Material and methods: a scoping review of the available literature describing thyroidization of the kidney in human renal pathology was done. 2 databases were screened - PubMed & Scopus. Eligible sources included original studies, case series, case reports, and reviews addressing histological features, mechanisms & clinical contexts of thyroidization. Support information extracted from relevant textbooks recognized as authoritative on the renal pathology field. Results: the literature associates thyroidization with chronic tubulointerstitial damage, mostly in chronic kidney disease of diverse etiologies. The pattern reflects tubular atrophy with proteinaceous casts, interstitial fibrosis and chronic inflammation. Clinical correlations are rarely assessed; the presence of thyroidization is usually interpreted as a marker of long-standing injury. Reports suggesting links with disease duration, recurrent infection, or poor renal outcome remain largely descriptive. Conclusions: thyroidization of the kidney is a reproducible and distinctive histological pattern that functions primarily as a morphological signpost of chronicity. Its potential value as a semi-quantitative marker of disease duration, prior injury burden, or prognosis has not been studied. Future work integrating digital pathology, quantitative morphometry, and clinicopathological correlation may clarify whether thyroidization carries information beyond that conveyed by established chronicity indices.

31 January 2026 in Quality in Sport
Verified
Journal Article
Open access
MKMateusz Kubicki
Mateusz Kubicki
PHPatryk Hebda
Patryk Hebda
RCRoman Cemaga
Roman Cemaga
BBBartłomiej Błaszkowski
Bartłomiej Błaszkowski
AWAdam Wolski
Adam Wolski
WMWiktoria Michnowska
Wiktoria Michnowska
Background: Acute and chronic pain is a very common problem amongst people involved in sports, whether professionally or recreationally. Most of them require the use of medication in order to alleviate the pain. Extensive use of pain medication is burdened with an increased risk of adverse effects. Aim: The aim of this narrative review is to summarise the adverse effects of the most popular pain management medication currently in use in sport medicine. Material and methods: A comprehensive literature review was conducted via the advanced research tool in PubMed in order to find eligible and relevant articles regarding pain medication and their adverse effects. Results: Extensive intake of NSAIDs in high doses increases the risk of gastrointestinal bleeding. The greatest concern regarding the use of paracetamol is its hepatotoxicity. Antidepressants are characterised by a wide variety of adverse effects, such as hypertension, dry mouth, constipation, and an increased risk of falls. The most common adverse effects of gabapentinoids are somnolence, fatigue, and dizziness. Conclusions: Most injuries experienced by athletes can be managed with NSAIDs, acetaminophen, and weak oral opioids prescribed for a short period of time, whereas chronic pain treatment should start with TCAs, SNRIs, or gabapentinoids. Prolonged intake of pain medication increases the risk of the occurrence of serious adverse effects. Physicians ought to monitor their patients and act accordingly should any adverse effects occur.

26 January 2026 in Quality in Sport
Verified
Journal Article
Open access
AWAdam Wolski
Adam Wolski
ESEwa Szplit
Ewa Szplit
MPMikołaj Patalong
Mikołaj Patalong
RCRoman Cemaga
Roman Cemaga
MKMateusz Kubicki
Mateusz Kubicki
KWKatarzyna Więckowska
Katarzyna Więckowska
Background: Psychedelic substances have been used for millennia in religious and healing contexts and have recently re-emerged as subjects of scientific interest due to advances in neuroscience and psychiatry. Research suggests that psychedelics may address limitations of conventional psychiatric treatments, particularly in disorders such as major depressive disorder, PTSD, substance use disorders, and anxiety disorders. Aim: This article aims to critically review and synthesize current evidence on the neurobiological mechanisms, therapeutic efficacy, and safety profiles of selected psychedelic substances—psilocybin, LSD, MDMA, and ketamine—in the treatment of psychiatric disorders. Materials and Methods: A literature review was conducted using databases including PubMed, Scopus, and Google Scholar. Clinical trials, meta-analyses, and reviews published in English between 2006 and 2025 were included. Studies addressing therapeutic outcomes, neurobiological mechanisms, and safety considerations of psychedelic-assisted therapies were analysed. Results: In publications included in this literature review, psilocybin demonstrated robust antidepressant effects, benefits in substance use disorders, and reductions in anxiety following limited dosing sessions. MDMA-assisted psychotherapy showed strong efficacy in PTSD, with high remission rates. LSD exhibited promising effects in anxiety and substance use disorders. Ketamine produced rapid antidepressant and anti-suicidal effects in depression and showed potential in addiction and anxiety, although results in PTSD were mixed. Conclusions: Psychedelic-assisted therapies represent a promising and scientifically credible expansion of psychiatric treatment options. While associated risks necessitate careful screening and clinical oversight, evidence supports their role as adjunctive or alternative interventions for selected patients, warranting further large-scale and long-term investigation.